Anomalie cardiache nel lupus eritematosus sistemico: prevalenza e relazione con durata, attività della malattia e presenza di anticorpi antifosfolipidi.

Translated title of the contribution: Cardiac anomalies in systemic lupus erythematosus: their prevalence and relation to duration, disease activity and the presence of antiphospholipid antibodies

C. Lolli, M. Foscoli, R. Giofrè, M. Tarquinii, S. Pasquali, G. P. Toschi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We conducted an echocardiographic study to determine the incidence and spectrum of morphologic and functional cardiac abnormalities in systemic lupus erythematosus (SLE) and to relate these findings to the disease activity and duration, and the presence of antiphospholipid (APL) antibodies. Thirty consecutive patients with LES (5 male and 25 female, mean age 37 +/- 11 years) were studied with a clinical cardiovascular examination and M-mode, 2-D Doppler echocardiogram. All patients fulfilled the American Rheumatism Association criteria for diagnosis of SLE. Disease activity was scored using the "Lupus Activity Criteria Count". The duration of the disease was less than 1 year in 5 patients (16.7%), between 1 and 5 years in 7 (23.3%), and superior to 5 years in 18 (60%). No patient had a history of rheumatic fever or infective endocarditis. All patients had received steroid therapy. In 26.7% of patients the disease was active, and in 33.3% APL antibodies were present. Patients were matched by number, age and sex with the control group. In 73.3% of the patients the echocardiogram resulted abnormal; valvular disease occurred in 30% and the echocardiographic features were of diffuse thickening, with 4 mitral and 2 aortic regurgitations. No valvular dysfunctions were significant, nor was Libman-Sacks endocarditis present. Pericardial disease, effusion or thickening was detected in 33.3% of the echocardiograms. Furthermore, there was one patient with left ventricular mild hypertrophy; 2 with a mild enlargement of the left ventricle with no segmental abnormalities of wall motion and no systolic disfunction; 8 patients (26.7%) were normal. Compared with the control group, patients with SLE had an increased prevalence of echocardiographic abnormalities, especially pericardial (p <0.001) and valvular (p <0.01). No association was found between activity, duration of the disease and prevalence of cardiac abnormalities. On the contrary, an association between the presence of APL antibodies and cardiac abnormalities at the echocardiographic examination was evident (p <0.05).

Original languageItalian
Pages (from-to)1125-1134
Number of pages10
JournalGiornale Italiano di Cardiologia
Volume23
Issue number11
Publication statusPublished - Nov 1993

Fingerprint

Antiphospholipid Antibodies
Systemic Lupus Erythematosus
Endocarditis
Control Groups
Aortic Valve Insufficiency
Rheumatic Fever
Pericardial Effusion
Left Ventricular Hypertrophy
Rheumatic Diseases
Heart Ventricles
Heart Diseases
Steroids

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Anomalie cardiache nel lupus eritematosus sistemico : prevalenza e relazione con durata, attività della malattia e presenza di anticorpi antifosfolipidi. / Lolli, C.; Foscoli, M.; Giofrè, R.; Tarquinii, M.; Pasquali, S.; Toschi, G. P.

In: Giornale Italiano di Cardiologia, Vol. 23, No. 11, 11.1993, p. 1125-1134.

Research output: Contribution to journalArticle

Lolli, C. ; Foscoli, M. ; Giofrè, R. ; Tarquinii, M. ; Pasquali, S. ; Toschi, G. P. / Anomalie cardiache nel lupus eritematosus sistemico : prevalenza e relazione con durata, attività della malattia e presenza di anticorpi antifosfolipidi. In: Giornale Italiano di Cardiologia. 1993 ; Vol. 23, No. 11. pp. 1125-1134.
@article{bbea4d2c6b4641cba0e3e5693a8e9c4e,
title = "Anomalie cardiache nel lupus eritematosus sistemico: prevalenza e relazione con durata, attivit{\`a} della malattia e presenza di anticorpi antifosfolipidi.",
abstract = "We conducted an echocardiographic study to determine the incidence and spectrum of morphologic and functional cardiac abnormalities in systemic lupus erythematosus (SLE) and to relate these findings to the disease activity and duration, and the presence of antiphospholipid (APL) antibodies. Thirty consecutive patients with LES (5 male and 25 female, mean age 37 +/- 11 years) were studied with a clinical cardiovascular examination and M-mode, 2-D Doppler echocardiogram. All patients fulfilled the American Rheumatism Association criteria for diagnosis of SLE. Disease activity was scored using the {"}Lupus Activity Criteria Count{"}. The duration of the disease was less than 1 year in 5 patients (16.7{\%}), between 1 and 5 years in 7 (23.3{\%}), and superior to 5 years in 18 (60{\%}). No patient had a history of rheumatic fever or infective endocarditis. All patients had received steroid therapy. In 26.7{\%} of patients the disease was active, and in 33.3{\%} APL antibodies were present. Patients were matched by number, age and sex with the control group. In 73.3{\%} of the patients the echocardiogram resulted abnormal; valvular disease occurred in 30{\%} and the echocardiographic features were of diffuse thickening, with 4 mitral and 2 aortic regurgitations. No valvular dysfunctions were significant, nor was Libman-Sacks endocarditis present. Pericardial disease, effusion or thickening was detected in 33.3{\%} of the echocardiograms. Furthermore, there was one patient with left ventricular mild hypertrophy; 2 with a mild enlargement of the left ventricle with no segmental abnormalities of wall motion and no systolic disfunction; 8 patients (26.7{\%}) were normal. Compared with the control group, patients with SLE had an increased prevalence of echocardiographic abnormalities, especially pericardial (p <0.001) and valvular (p <0.01). No association was found between activity, duration of the disease and prevalence of cardiac abnormalities. On the contrary, an association between the presence of APL antibodies and cardiac abnormalities at the echocardiographic examination was evident (p <0.05).",
author = "C. Lolli and M. Foscoli and R. Giofr{\`e} and M. Tarquinii and S. Pasquali and Toschi, {G. P.}",
year = "1993",
month = "11",
language = "Italian",
volume = "23",
pages = "1125--1134",
journal = "Giornale Italiano di Cardiologia",
issn = "0046-5968",
publisher = "Societa Italiana di Cardiologia",
number = "11",

}

TY - JOUR

T1 - Anomalie cardiache nel lupus eritematosus sistemico

T2 - prevalenza e relazione con durata, attività della malattia e presenza di anticorpi antifosfolipidi.

AU - Lolli, C.

AU - Foscoli, M.

AU - Giofrè, R.

AU - Tarquinii, M.

AU - Pasquali, S.

AU - Toschi, G. P.

PY - 1993/11

Y1 - 1993/11

N2 - We conducted an echocardiographic study to determine the incidence and spectrum of morphologic and functional cardiac abnormalities in systemic lupus erythematosus (SLE) and to relate these findings to the disease activity and duration, and the presence of antiphospholipid (APL) antibodies. Thirty consecutive patients with LES (5 male and 25 female, mean age 37 +/- 11 years) were studied with a clinical cardiovascular examination and M-mode, 2-D Doppler echocardiogram. All patients fulfilled the American Rheumatism Association criteria for diagnosis of SLE. Disease activity was scored using the "Lupus Activity Criteria Count". The duration of the disease was less than 1 year in 5 patients (16.7%), between 1 and 5 years in 7 (23.3%), and superior to 5 years in 18 (60%). No patient had a history of rheumatic fever or infective endocarditis. All patients had received steroid therapy. In 26.7% of patients the disease was active, and in 33.3% APL antibodies were present. Patients were matched by number, age and sex with the control group. In 73.3% of the patients the echocardiogram resulted abnormal; valvular disease occurred in 30% and the echocardiographic features were of diffuse thickening, with 4 mitral and 2 aortic regurgitations. No valvular dysfunctions were significant, nor was Libman-Sacks endocarditis present. Pericardial disease, effusion or thickening was detected in 33.3% of the echocardiograms. Furthermore, there was one patient with left ventricular mild hypertrophy; 2 with a mild enlargement of the left ventricle with no segmental abnormalities of wall motion and no systolic disfunction; 8 patients (26.7%) were normal. Compared with the control group, patients with SLE had an increased prevalence of echocardiographic abnormalities, especially pericardial (p <0.001) and valvular (p <0.01). No association was found between activity, duration of the disease and prevalence of cardiac abnormalities. On the contrary, an association between the presence of APL antibodies and cardiac abnormalities at the echocardiographic examination was evident (p <0.05).

AB - We conducted an echocardiographic study to determine the incidence and spectrum of morphologic and functional cardiac abnormalities in systemic lupus erythematosus (SLE) and to relate these findings to the disease activity and duration, and the presence of antiphospholipid (APL) antibodies. Thirty consecutive patients with LES (5 male and 25 female, mean age 37 +/- 11 years) were studied with a clinical cardiovascular examination and M-mode, 2-D Doppler echocardiogram. All patients fulfilled the American Rheumatism Association criteria for diagnosis of SLE. Disease activity was scored using the "Lupus Activity Criteria Count". The duration of the disease was less than 1 year in 5 patients (16.7%), between 1 and 5 years in 7 (23.3%), and superior to 5 years in 18 (60%). No patient had a history of rheumatic fever or infective endocarditis. All patients had received steroid therapy. In 26.7% of patients the disease was active, and in 33.3% APL antibodies were present. Patients were matched by number, age and sex with the control group. In 73.3% of the patients the echocardiogram resulted abnormal; valvular disease occurred in 30% and the echocardiographic features were of diffuse thickening, with 4 mitral and 2 aortic regurgitations. No valvular dysfunctions were significant, nor was Libman-Sacks endocarditis present. Pericardial disease, effusion or thickening was detected in 33.3% of the echocardiograms. Furthermore, there was one patient with left ventricular mild hypertrophy; 2 with a mild enlargement of the left ventricle with no segmental abnormalities of wall motion and no systolic disfunction; 8 patients (26.7%) were normal. Compared with the control group, patients with SLE had an increased prevalence of echocardiographic abnormalities, especially pericardial (p <0.001) and valvular (p <0.01). No association was found between activity, duration of the disease and prevalence of cardiac abnormalities. On the contrary, an association between the presence of APL antibodies and cardiac abnormalities at the echocardiographic examination was evident (p <0.05).

UR - http://www.scopus.com/inward/record.url?scp=0027700329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027700329&partnerID=8YFLogxK

M3 - Articolo

C2 - 8163102

AN - SCOPUS:0027700329

VL - 23

SP - 1125

EP - 1134

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 0046-5968

IS - 11

ER -